Cargando…

Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma

Adult T-cell leukemia/lymphoma (ATLL) is an aggressive, clonal malignancy of mature T cells caused by human T-cell leukemia virus type 1. Although it is a rare tumor type, it serves as an excellent model of a virus driven process that transforms cells and engenders a highly malignant tumor that is e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rauch, Daniel A., Harding, John C., Ratner, Lee, Wickline, Samuel A., Pan, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234599/ https://www.ncbi.nlm.nih.gov/pubmed/34208564 http://dx.doi.org/10.3390/nano11061582

Ejemplares similares

Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients
por: Rauch, Daniel A., et al.
Publicado: (2011)

NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis
por: Stansel, Tomoko, et al.
Publicado: (2020)

NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances
por: Wu, Xuesong, et al.
Publicado: (2023)

Development of a peptide-siRNA nanocomplex targeting NF- κB for efficient cartilage delivery
por: Yan, Huimin, et al.
Publicado: (2019)

Fumagillin Prodrug Nanotherapy Suppresses Macrophage Inflammatory Response via Endothelial Nitric Oxide
por: Zhou, Hui-fang, et al.
Publicado: (2014)

Tumor Microenvironment Targeted Nanotherapy
por: Fernandes, Clara, et al.
Publicado: (2018)

Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma
por: Rauch, Daniel A., et al.
Publicado: (2020)

Tet-inducible lymphoma in a new Tax transgenic mouse model
por: Rauch, Daniel, et al.
Publicado: (2011)

Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy
por: Poondru, Sneha, et al.
Publicado: (2022)

Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax Requires CADM1/TSLC1 for Inactivation of the NF-κB Inhibitor A20 and Constitutive NF-κB Signaling
por: Pujari, Rajeshree, et al.
Publicado: (2015)

Molecular targets in arthritis and recent trends in nanotherapy
por: Roy, Kislay, et al.
Publicado: (2015)

Biomimetic nanotherapy: core–shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma
por: Zhao, Qiangqiang, et al.
Publicado: (2021)

Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies
por: Ediriwickrema, Asiri, et al.
Publicado: (2015)

Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas
por: Koneru, Tejaswi, et al.
Publicado: (2021)

Imaging-assisted anticancer nanotherapy
por: Dasgupta, Anshuman, et al.
Publicado: (2020)

Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period
por: Savlı, Hakan, et al.
Publicado: (2016)

Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
por: Crintea, Andreea, et al.
Publicado: (2023)

NF-κB: A Druggable Target in Acute Myeloid Leukemia
por: Di Francesco, Barbara, et al.
Publicado: (2022)

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
por: Ratner, L, et al.
Publicado: (2016)

Bioactive multi-protein adsorption enables targeted mast cell nanotherapy
por: Du, Fanfan, et al.
Publicado: (2023)

Ormeloxifene nanotherapy for cervical cancer treatment
por: Chauhan, Neeraj, et al.
Publicado: (2019)

Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases
por: Li, Chen-Wen, et al.
Publicado: (2020)

Prediction of Anti-cancer Nanotherapy Efficacy by Imaging
por: Miller, Miles A., et al.
Publicado: (2017)

NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
por: Jayawant, Eleanor, et al.
Publicado: (2023)

The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches
por: Agrahari, Vivek
Publicado: (2017)

NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells
por: Pasqualucci, Laura, et al.
Publicado: (2022)

MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2021)

Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers
por: Leng, Fan, et al.
Publicado: (2018)

Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases
por: Yang, Guoyu, et al.
Publicado: (2019)

The effects of XMRV gene expression on the mouse prostate
por: Rauch, Daniel, et al.
Publicado: (2011)

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Burley, Thomas A., et al.
Publicado: (2022)

Foxp3 Represses Retroviral Transcription by Targeting Both NF-κB and CREB Pathways
por: Grant, Christian, et al.
Publicado: (2006)

Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment
por: Ratner, Lee
Publicado: (2019)

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
por: Pérez-Medina, Carlos, et al.
Publicado: (2016)

The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy
por: Khosravi-Darani, Kianoush, et al.
Publicado: (2007)

The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment
por: Zhang, Ye, et al.
Publicado: (2023)

Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer
por: Marcelo, Gonçalo A., et al.
Publicado: (2023)

N-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB
por: Kalac, Matko, et al.
Publicado: (2020)

RHAMM(B)-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment
por: Chen, Xiang, et al.
Publicado: (2021)

Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma
por: Daenthanasanmak, Anusara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2rupeusv5l5chbojth3mt9s3sv